Is PSYGF or DIVO a better dividend investment in 2026?

PSYGF currently yields 1574.80% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: PSYGF offers higher current income.

What is the dividend yield difference between PSYGF and DIVO?

PSYGF has a forward dividend yield of 1574.80% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 1568.18 percentage points.

Home › Compare › PSYGF vs DIVO

PSYGF vs DIVO: Dividend Comparison 2026

PSYGF yields 1574.80% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PSYGF wins by $1094146078.83M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PSYGF

● Live price

1574.80%

Share price

$0.13

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1094146078.86M

Annual income

$972,648,549,767,836.50

Full PSYGF calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — PSYGF vs DIVO

📍 PSYGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PSYGF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PSYGF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PSYGF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSYGF

Annual income on $10K today (after 15% tax)

$133,858.27/yr

After 10yr DRIP, annual income (after tax)

$826,751,267,302,661.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, PSYGF beats the other by $826,751,267,301,803.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSYGF + DIVO for your $10,000?

PSYGF: 50%DIVO: 50%

100% DIVO50/50100% PSYGF

Portfolio after 10yr

$547073039.45M

Annual income

$486,324,274,884,422.50/yr

Blended yield

88.90%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSYGF buys

DIVO buys

No recent congressional trades found for PSYGF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPSYGFDIVO

Forward yield	1574.80% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1094146078.86M ✓	$31.0K
Annual income after 10y	$972,648,549,767,836.50 ✓	$1,008.47
Total dividends collected	$1085342975.29M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PSYGF vs DIVO ($10,000, DRIP)

Year	PSYGF Portfolio	PSYGF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$168,180	$157,480.31	$11,362	$661.96	+$156.8K → PSYGF
2	$2,655,195	$2,475,241.96	$12,860	$702.91	+$2.64M → PSYGF
3	$39,363,107	$36,522,048.09	$14,504	$743.56	+$39.35M → PSYGF
4	$548,134,593	$506,016,068.87	$16,303	$783.73	+$548.12M → PSYGF
5	$7,171,846,637	$6,585,342,622.60	$18,268	$823.31	+$7171.83M → PSYGF
6	$88,200,293,754	$80,526,417,852.20	$20,408	$862.17	+$88200.27M → PSYGF
7	$1,019,911,005,360	$925,536,691,043.00	$22,737	$900.20	+$1019910.98M → PSYGF
8	$11,093,656,198,301	$10,002,351,422,566.60	$25,266	$937.31	+$11093656.17M → PSYGF
9	$113,549,092,609,754	$101,678,880,477,571.69	$28,008	$973.42	+$113549092.58M → PSYGF
10	$1,094,146,078,860,274	$972,648,549,767,836.50	$30,977	$1,008.47	+$1094146078.83M → PSYGF

PSYGF vs DIVO: Complete Analysis 2026

PSYGF — Stock

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

Full PSYGF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this PSYGF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSYGF vs SCHD PSYGF vs JEPI PSYGF vs O PSYGF vs KO PSYGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.